Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

Open Vet J. 2024; 14(9): 2433-2440


Multi-drug resistance and phylogenetic analyses of Pseudomonas aeruginosa based on the 16S rRNA gene of isolates recovered from clinical samples and their susceptibility to silver-nanoparticle

Zeena Fouad Saleh, Shujon Hassan Jadaan, Hiba Shehab Ahmed, Saba Falah Klaif, Shahad Mazin Daham.




Abstract

Background:
Pseudomonas aeruginosa is a highly antimicrobial-resistant pathogen with a very narrow range of effective antibacterial agents. Therefore, finding alternative compounds is highly required, such as silver nanoparticles (AgNPs).
Aim:
The current study was conducted to identify the multi-drug resistance (MDR) profile and perform a phylogenetic analysis on Pseudomonas aeruginosa isolates recovered from clinical samples (human, cows, cats, and fish) and to study their susceptibility to AgNPs.
Methods:
40 samples were subjected to conventional cultivation and biochemical analyses to identify P. aeruginosa. Moreover, these isolates were tested for their antibiotic resistance profile and their response to AgNPs using disk diffusion methods. PCR and Sanger-based sequencing were performed using the 16S rRNA gene as a target.
Results:
The results showed that all isolates were resistant to cefixime and sensitive to meropenem. Conversely, the AgNPs were effective in producing larger zones of inhibition. The PCR revealed amplification of the target, and the sequencing and phylogenetic tree of four isolates revealed close similarity with global human sequences from different regions.
Conclusion:
The study reveals MDR characteristics of Pseudomonas aeruginosa. The isolates are highly susceptible to silver nanoparticles.

Key words: Alternative medicine, Antibiotic resistance, Multi-drug resistance, Nosocomial infection, Pseudomonas aeruginosa






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.